10:28 AM EST - Trillium Therapeutics Inc. : Has received a notification letter from The NASDAQ Stock Market LLC notifying the Company that it is eligible for an additional 180-calendar-day period to regain compliance with the minimum bid price requirement set forth in NASDAQ Listing Rules for continued listing on the NASDAQ Capital Market. Trillium Therapeutics Inc.
shares T.TRIL are trading unchanged at $0.39.
